The recommended dosage of REMICADE® is 3 mg/kg IV given as an intravenous induction regimen at 0, 2, and 6 weeks, followed by a maintenance regimen of 3 mg/kg IV every 8 weeks thereafter for the treatment of moderately to severely active RA. REMICADE® should be given in combination with MTX.